These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25989920)

  • 41. The limited state of technology assessment for medical devices: facing the issues.
    Ramsey SD; Luce BR; Deyo R; Franklin G
    Am J Manag Care; 1998 Sep; 4 Spec No():SP188-99. PubMed ID: 10185994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Which barriers prevent the efficient use of resources in medical device sectors?
    Simoens S
    Appl Health Econ Health Policy; 2009; 7(4):209-17. PubMed ID: 19905034
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A review of the economic tools for assessing new medical devices.
    Craig JA; Carr L; Hutton J; Glanville J; Iglesias CP; Sims AJ
    Appl Health Econ Health Policy; 2015 Feb; 13(1):15-27. PubMed ID: 25139635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Price differences between Japan and the US for medical materials and how to reduce them.
    Ide H; Yasunaga H; Imamura T; Ohe K
    Health Policy; 2007 Jun; 82(1):71-7. PubMed ID: 17028042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost analyses in assistive technology research.
    Harris F; Sprigle S
    Assist Technol; 2003; 15(1):16-27. PubMed ID: 14760978
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing coverage decisions on medical devices: A retrospective analysis of 78 medical device appraisals for the Austrian hospital benefit catalogue 2008-2015.
    Kisser A; Tüchler H; Erdös J; Wild C
    Health Policy; 2016 Aug; 120(8):903-12. PubMed ID: 27344197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Economic evaluation in medical information technology: why the numbers don't add up.
    Eisenstein EL; Ortiz M; Anstrom KJ; Crosslin DR; Lobach DF
    AMIA Annu Symp Proc; 2006; 2006():914. PubMed ID: 17238533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Procurement of medical devices based on cost-effectiveness data.].
    Trippoli S
    Recenti Prog Med; 2017 Sep; 108(9):374-378. PubMed ID: 28901346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. How well do search filters perform in identifying economic evaluations in MEDLINE and EMBASE.
    Glanville J; Kaunelis D; Mensinkai S
    Int J Technol Assess Health Care; 2009 Oct; 25(4):522-9. PubMed ID: 19845982
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Assessing the quality of medical information technology economic evaluations: room for improvement.
    Eisenstein EL; Ortiz M; Anstrom KJ; Crosslin DR; Lobach DF
    AMIA Annu Symp Proc; 2006; 2006():234-8. PubMed ID: 17238338
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Medical device market in China.
    Boyer P; Morshed BI; Mussivand T
    Artif Organs; 2015 Jun; 39(6):520-5. PubMed ID: 25735659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ATTITUDES OF ORTHOPEDIC SPECIALISTS TOWARD EFFECTS OF MEDICAL DEVICE PURCHASING.
    Lingg M; Merida-Herrera E; Wyss K; Durán-Arenas L
    Int J Technol Assess Health Care; 2017 Jan; 33(1):46-53. PubMed ID: 28434426
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Examining the production costs of antiretroviral drugs.
    Pinheiro E; Vasan A; Kim JY; Lee E; Guimier JM; Perriens J
    AIDS; 2006 Aug; 20(13):1745-52. PubMed ID: 16931939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey.
    Hatz MH; Schreyögg J; Torbica A; Boriani G; Blankart CR
    Health Econ; 2017 Feb; 26 Suppl 1():124-144. PubMed ID: 28139093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries.
    ; Heintz E; Gerber-Grote A; Ghabri S; Hamers FF; Rupel VP; Slabe-Erker R; Davidson T
    Pharmacoeconomics; 2016 Jan; 34(1):59-76. PubMed ID: 26446858
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Guidelines for health technologies: specific guidance for oncology products in Canada.
    Mittmann N; Evans WK; Rocchi A; Longo CJ; Au HJ; Husereau D; Leighl NB; Isogai PK; Krahn MD; Peacock S; Marshall D; Coyle D; Taylor SC; Jacobs P; Oh PI
    Value Health; 2012 May; 15(3):580-5. PubMed ID: 22583470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease management.
    Cao Q; Postmus D; Hillege HL; Buskens E
    Value Health; 2013 Jun; 16(4):529-35. PubMed ID: 23796286
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Medical devices are different to pharmaceuticals in the Health Technology Assessment process.
    Ferguson M
    J Comp Eff Res; 2014 May; 3(3):217-9. PubMed ID: 24969145
    [No Abstract]   [Full Text] [Related]  

  • 60. Adapting health technology assessment for drugs, medical devices, and health programs: Methodological considerations from the Indian experience.
    Prinja S; Jyani G; Gupta N; Rajsekar K
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):859-868. PubMed ID: 33882762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.